BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1525789)

  • 21. [A new granular effervescent 10-mg formulation of cisapride in the treatment of gastroesophageal reflux].
    Grossi L; Di Felice F; Marzio L
    Clin Ter; 1993 Feb; 142(2):127-33. PubMed ID: 8472526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and tolerability of cisapride in a new formula of 10 mg effervescent capsules for the treatment of functional dyspepsia].
    Grossi L; Di Felice F; Marzio L
    Clin Ter; 1993 Jun; 142(6):521-7. PubMed ID: 8354045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
    Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine.
    Geldof H; Hazelhoff B; Otten MH
    Aliment Pharmacol Ther; 1993 Aug; 7(4):409-15. PubMed ID: 8218755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice.
    Dakkak M; Jones BP; Scott MG; Tooley PJ; Bennett JR
    Br J Clin Pract; 1994; 48(1):10-4. PubMed ID: 8179973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug therapy of gastrointestinal motility disorders].
    Jia B
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932
    [No Abstract]   [Full Text] [Related]  

  • 29. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
    Corazza GR; Biagi F; Albano O; Bianchi Porro G; Cheli R; Mazzacca G; Miglio F; Naccarato R; Quaglino D; Surrenti C; Verme G; Gasbarrini G
    Ital J Gastroenterol; 1996; 28(6):317-23. PubMed ID: 8891846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prokinetic drugs in digestive disorders].
    Carella G; Marra L
    Clin Ter; 1993 Sep; 143(3):219-24. PubMed ID: 8222553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cisapride efficacy in gastroesophageal reflux in children].
    Bottaro G; Rotolo N; Spina M; Azzaro F; Galletta C; Romano D; Castiglione N; Patanè R
    Pediatr Med Chir; 1993; 15(2):141-4. PubMed ID: 8321715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
    Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms].
    Jebbink HJ; Smout AJ; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1772-5. PubMed ID: 8371822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-finding of cisapride in non-ulcer dyspepsia.
    Verlinden M
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():31-5; discussion 72-3. PubMed ID: 2192504
    [No Abstract]   [Full Text] [Related]  

  • 37. Ranitidine in the treatment of non-ulcer dyspepsia. A placebo-controlled study in the Federal Republic of Germany.
    Müller P; Hotz J; Franz E; Simon B
    Arzneimittelforschung; 1994 Oct; 44(10):1130-2. PubMed ID: 7818586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effectiveness of ranitidine in non-ulcer dyspepsia (functional dyspepsia) in comparison with an antacid].
    Hotz J; Plein K; Bunke R
    Med Klin (Munich); 1994 Feb; 89(2):73-80, 107. PubMed ID: 8164599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A comparative study of cisapride versus metoclopramide in the treatment of symptomatic hiatal hernia].
    Brizuela R; Nodarse O; García I; León C; Arus E
    G E N; 1992; 46(2):121-4. PubMed ID: 1340812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.
    Jian R; Ducrot F; Ruskone A; Chaussade S; Rambaud JC; Modigliani R; Rain JD; Bernier JJ
    Dig Dis Sci; 1989 May; 34(5):657-64. PubMed ID: 2653742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.